Clinicopathologic significance of cytokine levels in esophageal squamous cell carcinoma

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1416-1422

  Zhu, Xin ^a   Fu, Wenyu ^b   Xu, Shenhua ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytokines; Esophageal squamous cell carcinoma; IFN ; IL 10; IL 2; IL 4; IL 5; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY WEIGHT; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOMETRIC BEAD ASSAY; CYTOMETRY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; TUMOR DIFFERENTIATION;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOKINES; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952371758     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sato F, Shimada Y, Selaru FM, Shibata D, Maeda M, Watanabe G, Mori Y, Stass SA, Imamura M, Meltzer SJ: Prediction of survival in patients with esophageal carcinoma using artificial neural networks. Cancer 2005; 103:1596-1605. (Pubitemid 40490020)
2. Ambs S, Marincola FM, Thurin M: Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy. Cancer Res 2008; 68:4031-4033.
3. Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K: Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 1994; 58:317-323. (Pubitemid 24254637)
4. Kumar R, Kamdar D, Madden L, Hills C, Crooks D, O'Brien D, Greenman J: Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep 2006; 15:1513-1516.
5. Matsuda A, Furukawa K, Takasaki H, Suzuki H, Kan H, Tsuruta H, Shinji S, Tajiri T: Preoperative oral immune-enhancing nutritional supplementation corrects TH1/TH2 imbalance in patients undergoing elective surgery for colorectal cancer. Dis Colon Rectum 2006; 49:507-516.
6. Chechlinska M, Duma A, Swierkowska K, Kaminska J, Steffen J: Sera of lung cancer patients affect the release of Th1, Th2 and monocyte-derived cytokines, and the expression of IL-2Ralpha by normal, stimulated mononuclear cells. Cell Mol Biol Lett 2004; 9:69-81. (Pubitemid 38560198)
7. Cao ZX, Chen XP, Wu ZD: Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003; 2:562-565.
8. Luczynski W, Stasiak-Barmuta A, Krawczuk-Rybak M, Malinowska I, Matysiak M, Mitura-Lesiuk M, Kowalczyk J, Jeromin A: Th1/Th2 balance in acute lymphoblastic leukemia in children. Przegl Lek 2004; 61:919-923. (In Polish)
9. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A et al: Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004; 110:252-266. (Pubitemid 38402005)
10. Ooi KG, Galatowicz G, Calder VL, Lightman SL: Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res 2006; 4:294-309.
11. van Sandick JW, Boermeester MA, Gisbertz SS, ten Berge IJ, Out TA, van der Pouw Kraan TC, van Lanschot JJ: Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome. Cancer Immunol Immunother 2003; 52:617-624. (Pubitemid 37268194)
12. Wang Y, Liu D, Chen P, Koeffler HP, Tong X, Xie D: Negative feedback regulation of IFN-gamma pathway by IFN regulatory factor 2 in esophageal cancers. Cancer Res 2008; 68:1136-1143. (Pubitemid 351272232)
13. Mahmoodi M, Mir MR, Daryaei P, Harirchi I, Rezaei N, Mohagheghi MA, Mousavi-Jarrahi A, Nahavandian B, Kavianpour M, Jafari A: Cytokine response following transthoracic and transhiatal esophagectomy in patients with esophageal cancer. Eur Cytokine Netw 2008; 19:92-98.
14. Asao H, Fu XY: Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J Biol Chem 2000; 275(2):867-874. (Pubitemid 30051128)
15. Dunn GP, Koebel CM, Schreiber RD: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6:836-848.
16. Hwang JH, Kim SW, Lee HJ, Yun HJ, Kim S, Jo DY: Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1. Int J Hematol 2006; 84:143-150. (Pubitemid 44343977)
17. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW: An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007; 245:717-725. (Pubitemid 46684101)
18. Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Tanaka H, Miki K, Kobayashi K, Morita K: Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery 2008; 144:729-735.
19. Law S, Kwong DL, Wong KH, Kwok KF, Wong J: The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 2006; 10:1301-1311. (Pubitemid 44781197)
20. Torres KC, Dutra WO, Gollob KJ: Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells. Hum Immunol 2004; 65:1328-1335. (Pubitemid 39535296)
21. Zhu Y, Chen L, Huang Z, Alkan S, Bunting KD, Wen R, Wang D, Huang H: Cutting edge: IL-5 primes Th2 cytokine-producing capacity in eosinophils through a STAT5-dependent mechanism. J Immunol 2004; 173:2918-2922."